Technical Analysis for ATNX - Athenex, Inc.

Grade Last Price % Change Price Change
grade B 18.64 -1.11% -0.21
ATNX closed down 1.11 percent on Thursday, July 19, 2018, on approximately normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical ATNX trend table...

Date Alert Name Type % Chg
Jul 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jul 18 180 Bullish Setup Bullish Swing Setup -1.11%
Jul 18 Inside Day Range Contraction -1.11%
Jul 17 Inside Day Range Contraction 0.49%
Jul 13 NR7 Range Contraction 0.70%
Jul 12 New Uptrend Bullish 0.00%
Jul 11 New Downtrend Bearish 4.25%
Jul 11 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 4.25%
Jul 11 Down 3 Days in a Row Weakness 4.25%
Jul 11 Down 4 Days in a Row Weakness 4.25%

Older signals for ATNX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies. The Company's technology platform is organized into three categories, including Oral Absorption Platform, Src Kinase Inhibitors and Symptom Therapeutics. The Company offers Oraxol, an oral formulation of paclitaxel; Orateacan, an oral formulation of Irinotecan; Oradoxel, an oral formulation of Docetaxel, and an oral formulation of Topotecan for the treatment of various types of cancers. Its Src Kinase Inhibitors include KX-01 (KX2-391) and KX-02 (KX2-361) oncology drug candidates. The Company's Symptom Therapeutics include CQ-01, which is used for the treatment of burn pruritus and scars; CQ-R1, which is used for the treatment of an irradiation-induced dermatitis, and an intranasal Granisetron used for the treatment of chemotherapy-induced nausea/vomiting.
Is ATNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.0
52 Week Low 13.16
Average Volume 435,532
200-Day Moving Average 16.8467
50-Day Moving Average 17.76
20-Day Moving Average 18.8495
10-Day Moving Average 18.56
Average True Range 0.7297
ADX 26.34
+DI 20.6219
-DI 15.1327
Chandelier Exit (Long, 3 ATRs ) 17.8109
Chandelier Exit (Short, 3 ATRs ) 19.8691
Upper Bollinger Band 19.8694
Lower Bollinger Band 17.8296
Percent B (%b) 0.4
BandWidth 10.821507
MACD Line 0.227
MACD Signal Line 0.3281
MACD Histogram -0.1011
Fundamentals Value
Market Cap 1.06 Billion
Num Shares 57.1 Million
EPS -3.47
Price-to-Earnings (P/E) Ratio -5.37
Price-to-Sales 47.88
Price-to-Book 7.97
PEG Ratio 0.98
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.48
Resistance 3 (R3) 19.50 19.23 19.34
Resistance 2 (R2) 19.23 19.02 19.23 19.29
Resistance 1 (R1) 18.94 18.89 18.81 18.92 19.25
Pivot Point 18.67 18.67 18.61 18.67 18.67
Support 1 (S1) 18.38 18.46 18.25 18.36 18.03
Support 2 (S2) 18.11 18.33 18.11 17.99
Support 3 (S3) 17.82 18.11 17.94
Support 4 (S4) 17.80